Suppression of hepatitis by DAA treatment may reduce inflammatory cytokines and preserve ASGPR function, thereby restoring the differentiation and proliferation potential of residual hepatocytes and improving the ability to synthesize albumin, prothrombin, and other substances. Here, F2 is linked to Hepatitis.